BioSpace News Archive

Recognized and respected leaders from technology, pharmacology, and health have joined Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI) as members of the Company’s General Advisory Council.

RxRevu, the nation’s leading provider of prescription decision support solutions, has partnered with athenahealth, a leading supplier of network-enabled software and services for medical groups and health systems nationwide, to deploy SwiftRx® Direct™ – RxRevu’s Real-Time Prescription Benefit solution – within athenahealth’s electronic hea

Medicx, a leading analytics driven healthcare marketing solutions company, announced today the addition of a new leadership position and advisory board to help drive the development of

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer announced today that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s Investigational New Drug (“IND”) application for 177Lu-omburtamab-DTPA

A recently published scientific study led by the Centre for Neurology Studies at HealthTech Connex and a research team from Simon Fraser University (SFU), reports the latest breakthroughs from Project Iron Soldier. Captain (retired) Trevor Greene,

Vaccine manufacturing and regulatory expert and business development and strategy leader bring further expertise as company advances RSV vaccine candidate into Phase 2 and scales production of an intranasal COVID-19 vaccine candidate for clinical trials REDWOOD CITY, Calif.--( BUSINESS WIRE )-- Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today the appointments of William

Enzolytics, Inc. (OTC PINK:ENZC) (or the “Company”) today announced the execution of a binding letter of intent (the “LOI”) to merge with BioClonetics Immunotherapeutics, Inc. (“BCLS” or “BioClonetics”) a biotech company located in Dallas Texas, replacing the earlier non-binding letter signed on September 12, 2020.

Sani Professional, the food safety division of Professional Disposables International (PDI), announced that three of its products have demonstrated effectiveness against the SARS-CoV-2 virus: No-Rinse Sanitizing Wipes, No-Rinse Sanitizing Spray and Disinfecting Wipes.

Continuing its leading research on human milk oligosaccharides (HMOs), DuPont Nutrition & Biosciences released the findings of a new study demonstrating the importance of probiotic strain specificity, even within a sub-species, when related to efficient utilization of Human Milk Oligosaccharides (HMOs).

Enclara Pharmacia, the market leader in comprehensive pharmacy management services to the hospice community, announced today the appointment of Mark Morse as Chief Executive Officer